Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.
about
Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en-gb
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@nl
type
label
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en-gb
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@nl
prefLabel
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en-gb
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@nl
P50
P356
P1433
P1476
Polymyalgia rheumatica develop ...... chronic lymphocytic leukaemia.
@en
P2093
Sanah Sajawal
Sarah L Mackie
P356
10.1136/BCR-2017-221065
P577
2017-11-08T00:00:00Z